MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$695K
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Other revenue
--702* 0 1,404
Research and development
200 484* 177 192
General and administrative
514 1,312* 547 915
Gain on sale of baergic
-51* --
Total operating expenses
-1,745* 724 1,107
Loss from operations
-714 -2,447* -724 297
Interest income
18 24* 34 31
Loss on common stock warrant liabilities
-0* 0 0
Change in fair value of warrant liabilities
-1 -16* 2 -1
Total other income
19 -32 32
Net loss
-695 -2,407* -692 329
Net loss attributable to non-controlling interests
0 -20* --6
Net loss attributable to common stockholders
-695 -2,387 -683 335
Basic EPS
-0.21 -0.789 -0.21 -
Basic Average Shares
3,293,729 3,026,277 3,183,558 3,183,558
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to common...-$695K Interest income$18K Change in fair value ofwarrant liabilities-$1K Net loss-$695K Total other income$19K Loss from operations-$714K General andadministrative$514K Research and development$200K

AVENUE THERAPEUTICS, INC. (ATXI)

AVENUE THERAPEUTICS, INC. (ATXI)